The national i-Lab competition has just unveiled its 2025 winners, with significant recognition for Southern France's health ecosystem: seven innovative companies from the Eurobiomed community are among the laureates, and one of them, Dolinnov, even secured a highly coveted i-Lab Grand Prize.
A true DeepTech excellence label, i-Lab stands as a flagship initiative of France 2030 to support the emergence of innovative technological companies. With grants up to 600,000 euros, this prestigious competition, which has already recognized over 3,800 projects since 1999, enables laureates to achieve crucial milestones in R&D, prototyping, and intellectual property.
Diversity of recognized health innovations
The awarded innovations attest to the excellence and diversity of health solutions developed in our region. The i-Lab 2025 competition thus recognized Dimicare's new generation of precision antibiotics, Spima Therapeutics' immunotherapies, Lymphodys' innovative treatment for secondary lymphedema, Neocor Therapeutics' gene therapies enabling cardiac regeneration, DeepPulseNeuro's minimally invasive epilepsy monitoring tool, and Massalia Therapeutics' innovative therapies against fibrosis and tumors.
Grand Prize for Dolinnov
Special mention goes to Dolinnov, which secured one of the 9 i-Lab Grand Prizes awarded by the jury. This is a significant recognition for this Montpellier-based biotech company, which develops a solution for chronic neuropathic and inflammatory pain.
Eurobiomed's expertise, combining internal knowledge of i-Lab application files, cross-functional insights from the Strategic Projects Council, and in-depth mastery of France 2030 initiatives, played a key role in the success of several of these projects. « Eurobiomed's support provided us with invaluable feedback from experts familiar with i-Lab applications. For me, this contribution was decisive in securing the funding », highlights Juan Garcia, CEO of DimiCare.
L’équipe Eurobiomed se tient d’ores et déjà prête à accompagner les pépites de l’édition 2026, si ce concours d’innovation vous intéresse venez-nous en parler !
